Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics

Abstract Background Oral cancer therapy-related cardiovascular (CV) toxicity has a wide variety of presentations including arrhythmia, cardiomyopathy, and myocardial infarction, but clinical evidence related to its management is limited. The purpose of this IRB-approved, single-center, retrospective...

Full description

Bibliographic Details
Main Authors: Karen Abboud, Godsfavour Umoru, Barry Trachtenberg, Veronica Ajewole
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Cardio-Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40959-024-00221-5